Close

Jump to:

  • Navigation
  • Content
  • Footer
On The Mend hero image

On The Mend

Follow

An online platform to motivate anyone during physical rehab and connect them to healthcare professionals.

100%
 - 
Funded 15 Oct 2021
£250,001 target
£258,199 from 114 investors
More
Less

Business overview

Location London, United Kingdom
Social media
Website www.onthemend.com/
Sectors Healthcare Digital B2B
Company number 10758082
Incorporation date 8 May 2017
More
Less

Investment summary

Type Equity
Valuation (pre-money) £2M
Equity offered 10.99%
Share price £8.46
Tax relief

EIS

More
Less

Business highlights

  • Tech platform designed by a patient, surgeon & physiotherapist
  • Accepted into Aviva-backed Founders Factory accelerator program
  • Product built and ready to launch initial pilots in the UK
  • Participating in a UK market worth £5bn and $160bn in the US
More
Less

Key features

  • Secondary Market
  • Seedrs nominee min. £16.92 +
  • Direct investment min. £15,000.00 +
  • Pay by Bank payments not accepted
  • Idea
  • Key Information
  • Team
  • Updates
  • Investors 114
  • Discussion
  • Documents

Idea

Introduction

Physical rehabilitation is daunting. We’re on a mission to transform it for everyone.

On The Mend is a platform that enables the delivery of a tailored physical rehabilitation plan for anyone suffering a problem with their tendons, muscles, bones or joints – something that affects 1 in 4 of the world’s population annually.

The NHS spends almost £5bn each year treating people with such conditions and orthopaedics now account for the biggest single category of elective surgery waiting lists. To make matters worse, one out of two people aren't following through with their home rehab, wasting a lot of precious healthcare resources.

The good news is that studies show how simply putting a greater emphasis on self-care can reduce the cost of physiotherapy treatment by up to 32%.

We have built an online platform which aims to transform the rehabilitation journey for everyone involved. For patients, we make it easier for them to stay active and engaged with their prescribed treatment plan through our mobile app, keeping them connected with healthcare professionals, and creating better outcomes for their rehab journey. For surgeons and physiotherapists, our platform aims to make it easier for them to manage their caseload, track their patients’ progress and collaborate more effectively with colleagues.

Our mobile application and web portal has been built, and is now ready to deploy in initial pilot programmes.

Substantial accomplishments to date

We have achieved significant traction over the past two years:

- Built a mobile application for patients and web portal for healthcare professionals that is ready to deploy across the UK and designed for rapid scale overseas.

- Compliance with industry standard regulations ISO 27001, GDPR, Cyber Essentials, and NHS Data Security & Protection Toolkit, required to operate in most UK hospital and community care settings.

- Built a team which represents all sides of the problem we’re addressing. Our co-founders include a patient, surgeon and physiotherapist.

- Added two seasoned healthcare industry executives to advise our board on team building, route-to-market, and commercialisation strategies.

- Accepted into the Aviva Insurance-backed Founders Factory accelerator programme, which is also a shareholder.

- Invited to present to multinational insurance executives at GenRe’s headquarters, reflecting the need for the innovative technology solution our team is bringing to the global healthcare industry.

- Successfully raised £142,000 at a pre-money valuation of £1,750,000 to fund the build of our platform, regulatory compliance, legal and operational costs.

- Starting the process of planning our first pilot study with a large London-based physiotherapy clinic.

- Strong interest from a US customer following previous overseas visits.

Monetisation strategy

We target our earliest paying customers to be those closest to the delivery of care: private surgeon groups, physiotherapy clinics, specialist orthopaedic centres or NHS hospitals/Trusts.

Our goal is to be paid by healthcare providers based on the number of active patient users in return for improving clinic productivity, enabling better connection with other providers in the system, creating a differentiated product offering and supporting digital transformation initiatives.

Once we establish a strong product-market fit with providers across the UK, US and elsewhere, we will start to target private health insurers, NHS Integrated Care Systems and medical device manufacturers, which stand to benefit from system-wide improvements.

Our objective is for these healthcare players to pay us for delivering seamless data flow through the healthcare system, a differentiated product offering, helping attract new private patients and improving state run efficiency to drive greater long-term capacity.

Use of proceeds

We have used our previous funding round to support product development, regulatory compliance and marketing including two trips to the US for early talks with a regional healthcare provider.

Building on the traction we have achieved to date, we are looking to raise £250,000 to secure and support early pilots with orthopaedic brands and to market the business in the UK where we will focus our efforts over the next 12 months.

A third of this funding will go towards the people, technology and regulatory costs associated with supporting all aspects of product maintenance and improvement, as part of the feedback we will be receiving from our pilots.

The remaining two-thirds of the budget will go towards supporting our pilots, marketing and other operational costs.

Beyond any early traction we achieve in the UK, we will start to re-engage overseas customers, including in the US.

Key Information

SEIS / EIS Tax Relief:

Please note that the company has £140,000 left of their SEIS allocation. £113,363 of the investment reflected in the campaign is not eligible for SEIS, so investment up to £253,363 in this round will be SEIS eligible and will be offered to investors on a first come first serve basis. The investment made after £253,363 has been reached will be EIS eligible.

Material Debt:

The company has the following outstanding loans:

1. £40,272 non-interest bearing loan from Wesley Fogel, Founder and Director of the company with no repayment date. The loan is to be repaid upon any of the following conditions being satisfied:
- The company raises cumulative EIS-eligible fundraising in excess of £12M.
- The company achieves £1M in annual revenue in a one year period.
- An exit event by investor majority.
- Wesley Fogel's departure from the company.

The funds raised from this investment round will not be used to repay these loans.

Shares for Services:

The company has a Shares for Services agreement in place with Technorely, a software development company. The services provided by Technorely to the company are ongoing and are charged on a monthly basis to cover the support and development of the platform.

The total monthly fee amounts to $13,210 (USD). Under the terms of the Service Agreement, 50% of the invoice is paid in cash by the business (monthly), and 50% is compensated by way of share issuance to Technorely (quarterly). The share price used in calculating the issuance of shares is based on the share price of the most recent funding round.

Share issuance to Technorely up until August 2021 has been factored into the pre-money figures in this campaign. This arrangement remains under constant review and the agreement can be terminated at any time with a 30-day notice period. The company plans to grow an in-house technology team once it is in a position to support such expansion. Based on their current business plan, the company will start to transition to this arrangement from Year 2 onwards.

Open an account to get access to the team members of On The Mend

Sign up

Already have an account? Log in

To comply with financial regulations, we can only show full campaign details to registered users.

Only shareholders can access this page

If you successfully purchase a share lot of this business, you will be granted access.

Buy shares

Only shareholders can access this page

If you successfully purchase a share lot of this business, you will be granted access.

Buy shares

Only shareholders can access this page

If you successfully purchase a share lot of this business, you will be granted access.

Buy shares

Only shareholders can access this page

If you successfully purchase a share lot of this business, you will be granted access.

Buy shares

Share on:

Investing involves risks, including loss of capital, illiquidity, lack of dividends and dilution, and should be done only as part of a diversified portfolio. Please read the Risk Warnings before investing. Investments should only be made by investors who understand these risks. Tax treatment depends on individual circumstances and is subject to change in future.

This webpage has been approved as a financial promotion by Seedrs Limited ("Seedrs"), which is authorised and regulated by the Financial Conduct Authority. It is not intended to be a promotion of any individual investment opportunity and is not an offer to the public. The summary information provided about investment opportunities on this webpage is intended solely to demonstrate the types of investments available on the Seedrs platform, and any investment decision should be made on the basis of the full campaign. Full campaigns are available to investors who have become authorised to invest on the Seedrs platform. All investment activities take place within the United Kingdom, and any person resident outside the United Kingdom should ensure that they are not subject to any local regulations before investing.

Seedrs does not make investment recommendations to you. No communications from Seedrs, through this website or any other medium, should be construed as an investment recommendation. Further, nothing on this website shall be considered an offer to sell, or a solicitation of an offer to buy, any security to any person in any jurisdiction to whom or in which such offer, solicitation or sale is unlawful. Seedrs does not provide legal, financial or tax advice of any kind. If you have any questions with respect to legal, financial or tax matters relevant to your interactions with Seedrs, you should consult a professional adviser.

Tax Relief (SEIS)

This business is eligible for SEIS relief - providing qualifying investors with income tax relief of 50% of their investment and certain other tax reliefs. Tax treatment depends on individual circumstances and is subject to change in future. Click to learn more.

Tax Relief (EIS)

This business is eligible for EIS relief - providing qualifying investors with income tax relief of 30% of their investment and certain other tax reliefs. Tax treatment depends on individual circumstances and is subject to change in future. Click to learn more.

Valuation (pre-money)

Valuation rounded from £2,043,513

This is the fully-diluted pre-money valuation of the business (i.e. before the new investment comes in and including issued options and other equity interests). In contrast, the post-money valuation is based on inclusion of the new investment in the value.

It is calculated as the pre-money valuation plus the amount of new investment. e.g. If Company A is ascribed a pre-money valuation of £1,200,000 by prospective investors investing £300,000, its post-money valuation is £1,500,000.

Pitch type

There are 5 types of investment pitch available on Seedrs.

  • Equity
  • Convertible
  • Fund
  • Cohort
  • Secondary

Investing in a regular equity campaign is the simplest and most common way to invest in a startup. You decide which business you want to invest in, and if the campaign hits its funding target then you will become one of their shareholders. As the company becomes more valuable, so do your shares; allowing you the opportunity to share in the future success of the business.

Learn more about pitch type on Seedrs

Equity Offered

The equity offered is the percentage of the company’s shares being issued in return for the amount of investment raised.

When the amount raised is less than 100%, the equity offered is based on the target raise. Once the company has raised over 100% it is based on the total raised.

In some scenarios, entrepreneurs may accept additional direct investment after closing their Seedrs campaign. Provided this is within 6 months of the closing and on the same terms, we do not typically offer pre-emption rights on that extra investment (where you have the opportunity to invest again to maintain your percentage shareholding).

Learn more about investing and pre-emption rights.

Seedrs nominee

This shows if you are able to choose, when making an investment, that you be represented by, and your shareholding be managed by, the Seedrs nominee.

Find out more

Custodian

If you invest in this Campaign, Seedrs will act as Custodian rather than provide our standard nominee service. This is due to the fact that the business is not directly involved in the share sale and Seedrs will not benefit from any rights under a shareholder agreement. As a result, Seedrs will handle administrative tasks as we do normally, but you will not have information or voting rights, updates from the business, preemption on future fundraising, or ongoing support about business trading activity.

Learn more about Custodian here

Secondary market

This shows if the business has opted-in or opted-out of allowing its shares to be bought and sold on the secondary market.

Find out more

Direct investment

This is an option to invest and hold shares 'directly' in the company (rather than via the Seedrs Nominee). This option is only available to those investing over the threshold amount, which is determined by the fundraising company.

If you choose to hold your shares directly, you will be responsible for any contractual or administrative arrangements with the company you are investing in.

Find out more

Payment options

We are not able to accept card payments for investments into this sector. You can pay for your investment by creating a bank transfer, using funds in your investment account or create a Pay by Bank payment. Your investment will only be completed once the funds have reached our account.

Business Involvement

This Campaign offers shares for sale in business that is not directly involved in this Campaign or the sale. As a result, the Campaign and post-investment experience, including investor rights, will differ from a business-led campaign on Seedrs. Most notably, the business will not engage with investors in the discussion forums both during and after the sale or provide any updates to investors.

Learn more here

Payment options

We are not able to accept Pay by Bank payments for investments into this sector. You can pay for your investment with a card payment, by creating a bank transfer or by using funds in your investment account. Your investment will only be completed once the funds have reached our account.

Drawdowns

This campaign offers the ability to pay for an investment by drawdowns.

Warning

You are following a link outside of www.seedrs.com.

None of the information in constitutes part of the campaign and it has not been approved or reviewed by Seedrs.

ContinueCancel